INTRA-CELLULAR THERAPIES INC revenue breakdown overview

INTRA-CELLULAR THERAPIES INC revenue for the last year amounted to 420.72 M EUR, the most of which — 420.72 M EUR — came from its highest performing source at the moment, Small Molecule Drugs, the year earlier bringing 233.88 M EUR. The greatest contribution to the revenue figure was made by United States — last year it brought INTRA-CELLULAR THERAPIES INC 420.72 M EUR, and the year before that — 233.88 M EUR.